SCHEMBL9019704

SCHEMBL9019704

CC(=O)Nc1ncc2c(ncn2COC(COCc2ccccc2)COC(=O)C(C)(C)C)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPR3 P17342 2/20 0.40
BCHE P06276 1/20 0.36
PRKCA P17252 1/20 0.35
PRKCD Q05655 1/20 0.35
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
AGER Q15109 1/20 0.33
TBXAS1 P24557 5/20 0.33
NPC1 O15118 2/20 0.32
GHSR Q92847 5/20 0.32
TP53 P04637 1/20 0.32
RAB9A P51151 1/20 0.32
TSHR P16473 1/20 0.32
FSHR P23945 1/20 0.32
CYP2C8 P10632 1/20 0.31
BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9019800 0.88 BCHE (0.38) BCHECYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL9019831 0.88 BCHE (0.38) BCHECYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL9020901 0.86 BCHE (0.48) NPR3BCHEPRKCAPRKCDCYP3A4
SCHEMBL9845246 0.82 BCHE (0.36) BCHECYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL9019826 0.81 ALDH1A1 (0.37) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
SCHEMBL9845278 0.80 SYK (0.31) CYP3A4CYP2C9CYP2C19CYP2D6TSHR
SCHEMBL8777016 0.77 ALDH1A1 (0.37) PRKCACYP3A4
SCHEMBL9019796 0.76 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL9575434 0.75 CYP1A2 (0.37) BCHECYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL9021602 0.74 ACHE (0.40) NPR3BCHEPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed